Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:15:07 UTC |
---|
HMDB ID | HMDB0000742 |
---|
Secondary Accession Numbers | - HMDB0000165
- HMDB00165
- HMDB00742
|
---|
Metabolite Identification |
---|
Common Name | Homocysteine |
---|
Description | Homocysteine (CAS: 454-29-5) is a sulfur-containing amino acid that arises during methionine metabolism. Although its concentration in plasma is only about 10 micromolar (uM), even moderate hyperhomocysteinemia is associated with an increased incidence of cardiovascular disease and Alzheimer's disease. Elevations in plasma homocysteine are commonly found as a result of vitamin deficiencies, polymorphisms of enzymes of methionine metabolism, and renal disease. It has been identified as a uremic toxin according to the European Uremic Toxin Working Group (PMID: 22626821 ). Pyridoxal, folic acid, riboflavin, and vitamin B(12) are all required for methionine metabolism, and deficiency of each of these vitamins result in elevated plasma homocysteine. A polymorphism of methylenetetrahydrofolate reductase (C677T), which is quite common in most populations with a homozygosity rate of 10-15 %, is associated with moderate hyperhomocysteinemia, especially in the context of marginal folate intake. Plasma homocysteine is inversely related to plasma creatinine in patients with renal disease. This is due to an impairment in homocysteine removal in renal disease. The role of these factors, and of modifiable lifestyle factors, in affecting methionine metabolism and in determining plasma homocysteine levels is discussed. Homocysteine is an independent cardiovascular disease (CVD) risk factor modifiable by nutrition and possibly exercise. Homocysteine was first identified as an important biological compound in 1932 and linked with human disease in 1962 when elevated urinary homocysteine levels were found in children with mental retardation. This condition, called homocystinuria, was later associated with premature occlusive CVD, even in children. These observations led to research investigating the relationship of elevated homocysteine levels and CVD in a wide variety of populations including middle age and elderly men and women with and without traditional risk factors for CVD (PMID: 17136938 , 15630149 ). Moreover, homocysteine is found to be associated with cystathionine beta-synthase deficiency, cystathioninuria, methylenetetrahydrofolate reductase deficiency, and sulfite oxidase deficiency, which are inborn errors of metabolism. |
---|
Structure | InChI=1S/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m0/s1 |
---|
Synonyms | Value | Source |
---|
Hcy | ChEBI | L-2-Amino-4-mercaptobutyric acid | ChEBI | L-2-Amino-4-mercaptobutyrate | Generator | 2-Amino-4-mercaptobutyric acid | HMDB | Homocysteine, L isomer | HMDB | L-Isomer homocysteine | HMDB | 2 Amino 4 mercaptobutyric acid | HMDB | Homocysteine, L-isomer | HMDB | (S)-2-Amino-4-mercapto-butanoate | HMDB | (S)-2-Amino-4-mercapto-butanoic acid | HMDB | (S)-2-Amino-4-mercaptobutanoic acid | HMDB | (S)-Homocysteine | HMDB | 2-Amino-4-mercapto-DL-butyrate | HMDB | 2-Amino-4-mercapto-DL-butyric acid | HMDB | 2-Amino-4-mercapto-L-butyric acid | HMDB | 2-Amino-4-mercapto-butanoate | HMDB | 2-Amino-4-mercapto-butanoic acid | HMDB | 2-Amino-4-mercapto-butyric acid | HMDB | 2-Amino-4-sulfanylbutanoate | HMDB | 2-Amino-4-sulfanylbutanoic acid | HMDB | D,L-Homocysteine | HMDB | DL-2-Amino-4-mercapto-butyric acid | HMDB | DL-2-Amino-4-mercaptobutyric acid | HMDB | DL-Homocysteine | HMDB | Homo-cys | HMDB | L-2-Amino-4-mercapto-butyric acid | HMDB | L-Homocysteine | HMDB | 2-Amino-4-mercapto-butyrate | HMDB | Homocysteine | MeSH, KEGG |
|
---|
Chemical Formula | C4H9NO2S |
---|
Average Molecular Weight | 135.185 |
---|
Monoisotopic Molecular Weight | 135.035399227 |
---|
IUPAC Name | (2S)-2-amino-4-sulfanylbutanoic acid |
---|
Traditional Name | L-homocysteine |
---|
CAS Registry Number | 6027-13-0 |
---|
SMILES | N[C@@H](CCS)C(O)=O |
---|
InChI Identifier | InChI=1S/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m0/s1 |
---|
InChI Key | FFFHZYDWPBMWHY-VKHMYHEASA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | L-alpha-amino acids |
---|
Alternative Parents | |
---|
Substituents | - L-alpha-amino acid
- Thia fatty acid
- Fatty acid
- Fatty acyl
- Amino acid
- Alkylthiol
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Primary amine
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Primary aliphatic amine
- Organic oxygen compound
- Carbonyl group
- Amine
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 232 - 233 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 148 mg/mL | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M-H]- | Astarita_neg | 119.3 | 30932474 | [M-H]- | Baker | 159.62 | 30932474 | [M+H]+ | Baker | 130.531 | 30932474 |
|
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Homocysteine,1TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H](N)CCS | 1357.5 | Semi standard non polar | 33892256 | Homocysteine,1TMS,isomer #2 | C[Si](C)(C)SCC[C@H](N)C(=O)O | 1502.8 | Semi standard non polar | 33892256 | Homocysteine,1TMS,isomer #3 | C[Si](C)(C)N[C@@H](CCS)C(=O)O | 1435.1 | Semi standard non polar | 33892256 | Homocysteine,2TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H](N)CCS[Si](C)(C)C | 1543.5 | Semi standard non polar | 33892256 | Homocysteine,2TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H](N)CCS[Si](C)(C)C | 1619.2 | Standard non polar | 33892256 | Homocysteine,2TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H](N)CCS[Si](C)(C)C | 2156.5 | Standard polar | 33892256 | Homocysteine,2TMS,isomer #2 | C[Si](C)(C)N[C@@H](CCS)C(=O)O[Si](C)(C)C | 1479.9 | Semi standard non polar | 33892256 | Homocysteine,2TMS,isomer #2 | C[Si](C)(C)N[C@@H](CCS)C(=O)O[Si](C)(C)C | 1490.3 | Standard non polar | 33892256 | Homocysteine,2TMS,isomer #2 | C[Si](C)(C)N[C@@H](CCS)C(=O)O[Si](C)(C)C | 1729.0 | Standard polar | 33892256 | Homocysteine,2TMS,isomer #3 | C[Si](C)(C)N[C@@H](CCS[Si](C)(C)C)C(=O)O | 1627.3 | Semi standard non polar | 33892256 | Homocysteine,2TMS,isomer #3 | C[Si](C)(C)N[C@@H](CCS[Si](C)(C)C)C(=O)O | 1612.6 | Standard non polar | 33892256 | Homocysteine,2TMS,isomer #3 | C[Si](C)(C)N[C@@H](CCS[Si](C)(C)C)C(=O)O | 2081.6 | Standard polar | 33892256 | Homocysteine,2TMS,isomer #4 | C[Si](C)(C)N([C@@H](CCS)C(=O)O)[Si](C)(C)C | 1565.1 | Semi standard non polar | 33892256 | Homocysteine,2TMS,isomer #4 | C[Si](C)(C)N([C@@H](CCS)C(=O)O)[Si](C)(C)C | 1499.3 | Standard non polar | 33892256 | Homocysteine,2TMS,isomer #4 | C[Si](C)(C)N([C@@H](CCS)C(=O)O)[Si](C)(C)C | 1906.0 | Standard polar | 33892256 | Homocysteine,3TMS,isomer #1 | C[Si](C)(C)N[C@@H](CCS[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1651.6 | Semi standard non polar | 33892256 | Homocysteine,3TMS,isomer #1 | C[Si](C)(C)N[C@@H](CCS[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1676.4 | Standard non polar | 33892256 | Homocysteine,3TMS,isomer #1 | C[Si](C)(C)N[C@@H](CCS[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1755.7 | Standard polar | 33892256 | Homocysteine,3TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](CCS)N([Si](C)(C)C)[Si](C)(C)C | 1628.1 | Semi standard non polar | 33892256 | Homocysteine,3TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](CCS)N([Si](C)(C)C)[Si](C)(C)C | 1639.6 | Standard non polar | 33892256 | Homocysteine,3TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@H](CCS)N([Si](C)(C)C)[Si](C)(C)C | 1739.0 | Standard polar | 33892256 | Homocysteine,3TMS,isomer #3 | C[Si](C)(C)SCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1790.4 | Semi standard non polar | 33892256 | Homocysteine,3TMS,isomer #3 | C[Si](C)(C)SCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1750.6 | Standard non polar | 33892256 | Homocysteine,3TMS,isomer #3 | C[Si](C)(C)SCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1905.9 | Standard polar | 33892256 | Homocysteine,4TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CCS[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1825.8 | Semi standard non polar | 33892256 | Homocysteine,4TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CCS[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1805.5 | Standard non polar | 33892256 | Homocysteine,4TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CCS[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1703.5 | Standard polar | 33892256 | Homocysteine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](N)CCS | 1605.7 | Semi standard non polar | 33892256 | Homocysteine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)SCC[C@H](N)C(=O)O | 1738.9 | Semi standard non polar | 33892256 | Homocysteine,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@@H](CCS)C(=O)O | 1695.9 | Semi standard non polar | 33892256 | Homocysteine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](N)CCS[Si](C)(C)C(C)(C)C | 2009.2 | Semi standard non polar | 33892256 | Homocysteine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](N)CCS[Si](C)(C)C(C)(C)C | 2069.2 | Standard non polar | 33892256 | Homocysteine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](N)CCS[Si](C)(C)C(C)(C)C | 2244.6 | Standard polar | 33892256 | Homocysteine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@@H](CCS)C(=O)O[Si](C)(C)C(C)(C)C | 1948.0 | Semi standard non polar | 33892256 | Homocysteine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@@H](CCS)C(=O)O[Si](C)(C)C(C)(C)C | 1925.4 | Standard non polar | 33892256 | Homocysteine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@@H](CCS)C(=O)O[Si](C)(C)C(C)(C)C | 1976.6 | Standard polar | 33892256 | Homocysteine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@@H](CCS[Si](C)(C)C(C)(C)C)C(=O)O | 2117.4 | Semi standard non polar | 33892256 | Homocysteine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@@H](CCS[Si](C)(C)C(C)(C)C)C(=O)O | 2052.6 | Standard non polar | 33892256 | Homocysteine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@@H](CCS[Si](C)(C)C(C)(C)C)C(=O)O | 2189.1 | Standard polar | 33892256 | Homocysteine,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N([C@@H](CCS)C(=O)O)[Si](C)(C)C(C)(C)C | 2035.0 | Semi standard non polar | 33892256 | Homocysteine,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N([C@@H](CCS)C(=O)O)[Si](C)(C)C(C)(C)C | 1949.8 | Standard non polar | 33892256 | Homocysteine,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N([C@@H](CCS)C(=O)O)[Si](C)(C)C(C)(C)C | 2049.7 | Standard polar | 33892256 | Homocysteine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CCS[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2314.8 | Semi standard non polar | 33892256 | Homocysteine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CCS[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2315.1 | Standard non polar | 33892256 | Homocysteine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CCS[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2130.8 | Standard polar | 33892256 | Homocysteine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCS)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2318.7 | Semi standard non polar | 33892256 | Homocysteine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCS)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2288.1 | Standard non polar | 33892256 | Homocysteine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCS)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2048.9 | Standard polar | 33892256 | Homocysteine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)SCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2470.5 | Semi standard non polar | 33892256 | Homocysteine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)SCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2370.8 | Standard non polar | 33892256 | Homocysteine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)SCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2198.3 | Standard polar | 33892256 | Homocysteine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCS[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2702.7 | Semi standard non polar | 33892256 | Homocysteine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCS[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2594.6 | Standard non polar | 33892256 | Homocysteine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCS[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2190.7 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Homocysteine GC-EI-TOF (Non-derivatized) | splash10-004i-0920000000-20fbffbe76510c066e6f | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Homocysteine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9000000000-1f800d28bca4b2b7a49f | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Homocysteine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Homocysteine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Homocysteine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Homocysteine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Homocysteine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Homocysteine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Homocysteine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Homocysteine LC-ESI-ITFT , positive-QTOF | splash10-014l-4900000000-c50d79ba3a5013bcf29f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Homocysteine LC-ESI-ITFT , positive-QTOF | splash10-000i-9000000000-025c9e1f4fb58138c43b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Homocysteine LC-ESI-ITFT , positive-QTOF | splash10-014i-4900000000-33f205e002f49f034764 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Homocysteine 35V, Positive-QTOF | splash10-052r-0900000000-c1f98c8182b5ddc09cb1 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homocysteine 10V, Positive-QTOF | splash10-00ko-9800000000-80a1c80328e8836233a4 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homocysteine 20V, Positive-QTOF | splash10-0006-9100000000-1f611da44349ffdfaefe | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homocysteine 40V, Positive-QTOF | splash10-0bvi-9000000000-c9d62a66522e46a17f56 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homocysteine 10V, Negative-QTOF | splash10-001i-3900000000-e8322d5858cba16a3bd2 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homocysteine 20V, Negative-QTOF | splash10-00lr-6900000000-e0190a1cc33e605bac0a | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homocysteine 40V, Negative-QTOF | splash10-001i-9000000000-900bb5d8fb11bec02e39 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homocysteine 10V, Negative-QTOF | splash10-001i-0900000000-38e427e24202b2411597 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homocysteine 20V, Negative-QTOF | splash10-001i-7900000000-5cf2133d9faac56032d3 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homocysteine 40V, Negative-QTOF | splash10-001i-9000000000-942ac689538269d6ca7b | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homocysteine 10V, Positive-QTOF | splash10-0006-9000000000-166428542631f9ac0714 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homocysteine 20V, Positive-QTOF | splash10-0a4i-9000000000-9bcb57b924579a6c3411 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Homocysteine 40V, Positive-QTOF | splash10-0a4j-9000000000-8eee886864db64f3eec2 | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2019-05-22 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2019-05-22 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm (predicted from logP)
|
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Feces
- Saliva
- Urine
|
---|
Tissue Locations | - Adipose Tissue
- Brain
- Fibroblasts
- Intestine
- Kidney
- Liver
- Neuron
- Pancreas
- Placenta
- Platelet
- Skeletal Muscle
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 9.4 (7.3-16.2) uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | 9.8 (7.6-14.9) uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 1-18 uM | Infant (0-1 year old) | Both | Normal | | details | Blood | Detected and Quantified | <7.500 uM | Not Specified | Not Specified | Normal | | details | Blood | Detected and Quantified | 2.89-9.99 uM | Infant (5 days - <1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 2.74-7.62 uM | Children (1 - <7 years old) | Both | Normal | | details | Blood | Detected and Quantified | 3.40-8.43 uM | Children (7 - <12 years old) | Both | Normal | | details | Blood | Detected and Quantified | 4.069-10.36 uM | Adolescent (12 - <15 years old) | Female | Normal | | details | Blood | Detected and Quantified | 4.96-11.91 uM | Adolescent (15 - <19 years old) | Female | Normal | | details | Blood | Detected and Quantified | 4.73-10.43 uM | Adolescent (12 - <15 years old) | Male | Normal | | details | Blood | Detected and Quantified | 5.47-13.39 uM | Adolescent (15 - <19 years old) | Male | Normal | | details | Blood | Detected and Quantified | 5.00 +/- 1.6 uM | Infant (0-1 year old) | Both | Normal | | details | Blood | Detected and Quantified | 10.4 +/- 2.3 uM | Children (1-13 years old) | Both | Normal | | details | Blood | Detected and Quantified | 9.00 +/- 2.2 uM | Adolescent (13-18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 9.00 +/- 2.00 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | <20 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 3-8 uM | Newborn (0-30 days old) | Both | Normal | | details | Blood | Detected and Quantified | 9.99 +/- 1.04 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 8-18 uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected and Quantified | <12.593 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 10.900 +/- 2.800 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 11.600 +/- 3 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 12.600 +/- 3.100 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 13.300 +/- 2.900 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 5.600 +/- 1.200 uM | Adult (>18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 9.11 +/- 2.99 uM | Adult (>18 years old) | Not Specified | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 4-12 uM | Children (1-13 years old) | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.09 (0.06-0.16) uM | Adult (>18 years old) | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 20.7 +/- 1.7 uM | Elderly (>65 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.057 +/- 0.035 uM | Adult (>18 years old) | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.12 +/- 0.08 uM | Elderly (>65 years old) | Not Specified | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.15 +/- 0.07 uM | Adult (>18 years old) | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 6.6 +/- 8.0 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected and Quantified | 2.92 +/- 2.27 uM | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.91-1.4 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 1.1 (0.6-1.74) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 2.00 +/- 1.65 umol/mmol creatinine | Infant (0-1 year old) | Male | Normal | | details | Urine | Detected and Quantified | 1.5 +/- 0.69 umol/mmol creatinine | Children (1-13 years old) | Male | Normal | | details | Urine | Detected and Quantified | 1.78 +/- 0.73 umol/mmol creatinine | Adolescent (13-18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 1.95 +/- 1.47 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 0.86-1.2 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 12.9 (8.2-28.2) uM | Adult (>18 years old) | Not Specified | Dementia (Alzheimer's and non-Alzheimer's) | | details | Blood | Detected and Quantified | 10.7 (7.6-14.4) uM | Adult (>18 years old) | Not Specified | Multiple sclerosis | | details | Blood | Detected and Quantified | 10.2 (7.0-17.4) uM | Adult (>18 years old) | Not Specified | Stroke | | details | Blood | Detected and Quantified | 11.9 (7.0-19.1) uM | Adult (>18 years old) | Not Specified | Peripheral neuropathy | | details | Blood | Detected and Quantified | 20.5 uM | Children (1-13 years old) | Female | Cystathioninuria | | details | Blood | Detected and Quantified | 19 uM | Children (1-13 years old) | Female | Cystathioninuria | | details | Blood | Detected and Quantified | 21.0 (18.5-25.7) uM | Adult (>18 years old) | Both | Chronic renal failure | | details | Blood | Detected and Quantified | 3.5 uM | Children (1-13 years old) | Female | Cystathioninuria | | details | Blood | Detected and Quantified | 25.5 (16.9-32.6) uM | Adult (>18 years old) | Both | Continuous ambulatory peritoneal dialysis (CAPD) | | details | Blood | Detected and Quantified | 29.7 (25.7-38.2) uM | Adult (>18 years old) | Both | Hemodialysis | | details | Blood | Detected and Quantified | <0.700 uM | Infant (0-1 year old) | Male | Sulfite oxidase deficiency | | details | Blood | Detected and Quantified | 68.80 +/- 15.53 uM | Adult (>18 years old) | Both | uremia | | details | Blood | Detected and Quantified | 3.8 uM | Infant (0-1 year old) | Female | Pyroglutamic aciduria | | details | Blood | Detected and Quantified | 12.5 +/- 5.0 uM | Adult (>18 years old) | Both | Sickle cell anemia | | details | Blood | Detected and Quantified | 180 uM | Adult (>18 years old) | Male | Methylenetetrahydrofolate reductase deficiency | | details | Blood | Detected and Quantified | <1.000 uM | Newborn (0-30 days old) | Female | Molybdenum cofactor deficiency | | details | Blood | Detected and Quantified | 12 uM | Adult (>18 years old) | Male | Dimethylglycinuria | | details | Blood | Detected and Quantified | 60 +/- 11.852 uM | Adult (>18 years old) | Both | Uremia | | details | Blood | Detected and Quantified | 125.00 (50.00-200.00) uM | Children (1-13 years old) | Both | Cystathionine beta-synthase deficiency | | details | Blood | Detected and Quantified | 6.00 (4.8-7.40) uM | Adult (>18 years old) | Both | Homocystinuria | | details | Blood | Detected and Quantified | 9.22 +/- 1.81 uM | Adult (>18 years old) | Not Specified | Cruetzfeldt-Jakob disease | | details | Blood | Detected and Quantified | 15.1 uM | Adult (>18 years old) | Both | Parkinson's disease | | details | Blood | Detected and Quantified | 13.94 +/- 3.47 uM | Adult (>18 years old) | Both | Amyotrophic lateral sclerosis | | details | Blood | Detected and Quantified | 15.75 +/- 5.75 uM | Adult (>18 years old) | Both | Progressive supranuclear palsy | | details | Blood | Detected and Quantified | 0.9 uM | Children (1-13 years old) | Male | Molybdenium co-factor deficiency | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.08 (0.05-0.16) uM | Adult (>18 years old) | Not Specified | Multiple sclerosis | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.08 (0.06-0.15) uM | Adult (>18 years old) | Not Specified | Stroke | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.11 (0.07-0.18) uM | Adult (>18 years old) | Not Specified | Peripheral neuropathy | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.216 +/- 0.122 uM | Adult (>18 years old) | Not Specified | Alzheimer's disease | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.12 +/- 0.062 uM | Elderly (>65 years old) | Not Specified | Alzheimer's disease | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.10 (0.06–0.32) uM | Adult (>18 years old) | Not Specified | Dementia (Alzheimer's and non-Alzheimer's) | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 14.2 +/- 1.7 uM | Elderly (>65 years old) | Not Specified | Alzheimer's disease | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.13 +/- 0.03 uM | Adult (>18 years old) | Not Specified | Cruetzfeldt-Jakob disease | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Oral squamous cell carcinoma (OSCC) | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Oral leukoplakia (OLK) | | details | Urine | Detected and Quantified | 0.470-0.500 umol/mmol creatinine | Newborn (0-30 days old) | Female | Transcobalamin II deficiency | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Creutzfeldt-Jakob disease |
---|
- Bleich S, Otto M, Zerr I, Kropp S, Kretzschmar HA, Wiltfang J: Creutzfeldt-Jakob disease and homocysteine levels in plasma and cerebrospinal fluid. Gerontology. 2005 Mar-Apr;51(2):142-4. [PubMed:15711082 ]
- [No authors listed] [PubMed:115711082 ]
| Sickle cell anemia |
---|
- van der Dijs FP, Schnog JJ, Brouwer DA, Velvis HJ, van den Berg GA, Bakker AJ, Duits AJ, Muskiet FD, Muskiet FA: Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients. Am J Hematol. 1998 Nov;59(3):192-8. [PubMed:9798656 ]
| Multiple sclerosis |
---|
- Obeid R, Kasoha M, Knapp JP, Kostopoulos P, Becker G, Fassbender K, Herrmann W: Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid. Clin Chem. 2007 Jun;53(6):1129-36. Epub 2007 Mar 23. [PubMed:17384003 ]
| Stroke |
---|
- Obeid R, Kasoha M, Knapp JP, Kostopoulos P, Becker G, Fassbender K, Herrmann W: Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid. Clin Chem. 2007 Jun;53(6):1129-36. Epub 2007 Mar 23. [PubMed:17384003 ]
| Peripheral neuropathy |
---|
- Obeid R, Kasoha M, Knapp JP, Kostopoulos P, Becker G, Fassbender K, Herrmann W: Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid. Clin Chem. 2007 Jun;53(6):1129-36. Epub 2007 Mar 23. [PubMed:17384003 ]
| Chronic renal failure |
---|
- McGregor DO, Dellow WJ, Lever M, George PM, Robson RA, Chambers ST: Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney Int. 2001 Jun;59(6):2267-72. [PubMed:11380830 ]
| Continuous ambulatory peritoneal dialysis |
---|
- McGregor DO, Dellow WJ, Lever M, George PM, Robson RA, Chambers ST: Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney Int. 2001 Jun;59(6):2267-72. [PubMed:11380830 ]
| Hemodialysis |
---|
- McGregor DO, Dellow WJ, Lever M, George PM, Robson RA, Chambers ST: Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney Int. 2001 Jun;59(6):2267-72. [PubMed:11380830 ]
| Homocystinuria |
---|
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| Parkinson's disease |
---|
- Levin J, Botzel K, Giese A, Vogeser M, Lorenzl S: Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis. Dement Geriatr Cogn Disord. 2010;29(6):553-9. doi: 10.1159/000314841. Epub 2010 Jul 3. [PubMed:20606437 ]
| Amyotrophic lateral sclerosis |
---|
- Levin J, Botzel K, Giese A, Vogeser M, Lorenzl S: Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis. Dement Geriatr Cogn Disord. 2010;29(6):553-9. doi: 10.1159/000314841. Epub 2010 Jul 3. [PubMed:20606437 ]
| Progressive supranuclear palsy |
---|
- Levin J, Botzel K, Giese A, Vogeser M, Lorenzl S: Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis. Dement Geriatr Cogn Disord. 2010;29(6):553-9. doi: 10.1159/000314841. Epub 2010 Jul 3. [PubMed:20606437 ]
| Uremia |
---|
- Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24. [PubMed:22626821 ]
- Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003 May;63(5):1934-43. doi: 10.1046/j.1523-1755.2003.00924.x. [PubMed:12675874 ]
| Sulfite oxidase deficiency, ISOLATED |
---|
- Choong T. et al. (2010). Clinical and Laboratory Barriers to the Timely Diagnosis of Sulphite Oxidase Deficiency. Proceedings of Singapore Healthcare, 19(2), 94-100.. Proceedings of Singapore Healthcare.
| Methylenetetrahydrofolate reductase deficiency |
---|
- Haworth JC, Dilling LA, Surtees RA, Seargeant LE, Lue-Shing H, Cooper BA, Rosenblatt DS: Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers. Am J Med Genet. 1993 Mar 1;45(5):572-6. [PubMed:8456826 ]
| Molybdenum cofactor deficiency |
---|
- Sass JO, Kishikawa M, Puttinger R, Reiss J, Erwa W, Shimizu A, Sperl W: Hypohomocysteinaemia and highly increased proportion of S-sulfonated plasma transthyretin in molybdenum cofactor deficiency. J Inherit Metab Dis. 2003;26(1):80-2. [PubMed:12872846 ]
| Cystathioninuria |
---|
- Espinos C, Garcia-Cazorla A, Martinez-Rubio D, Martinez-Martinez E, Vilaseca MA, Perez-Duenas B, Kozich V, Palau F, Artuch R: Ancient origin of the CTH alelle carrying the c.200C>T (p.T67I) variant in patients with cystathioninuria. Clin Genet. 2010 Dec;78(6):554-9. doi: 10.1111/j.1399-0004.2010.01431.x. [PubMed:20584029 ]
| Molybdenium co-factor deficiency |
---|
- Nagappa M, Bindu PS, Taly AB, Sinha S, Bharath RD: Child Neurology: Molybdenum cofactor deficiency. Neurology. 2015 Dec 8;85(23):e175-8. doi: 10.1212/WNL.0000000000002194. [PubMed:26644055 ]
| Dimethylglycine Dehydrogenase Deficiency |
---|
- Moolenaar SH, Poggi-Bach J, Engelke UF, Corstiaensen JM, Heerschap A, de Jong JG, Binzak BA, Vockley J, Wevers RA: Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism: NMR spectroscopy study. Clin Chem. 1999 Apr;45(4):459-64. [PubMed:10102904 ]
| Dementia |
---|
- Obeid R, Kasoha M, Knapp JP, Kostopoulos P, Becker G, Fassbender K, Herrmann W: Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid. Clin Chem. 2007 Jun;53(6):1129-36. Epub 2007 Mar 23. [PubMed:17384003 ]
| Alzheimer's disease |
---|
- Selley ML, Close DR, Stern SE: The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):383-8. [PubMed:11959400 ]
- Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1585-7. [PubMed:16227558 ]
- Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K: Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol. 2011;65(5):270-8. doi: 10.1159/000326301. Epub 2011 Apr 8. [PubMed:21474939 ]
| Colorectal cancer |
---|
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Transcobalamin II deficiency |
---|
- Bibi H, Gelman-Kohan Z, Baumgartner ER, Rosenblatt DS: Transcobalamin II deficiency with methylmalonic aciduria in three sisters. J Inherit Metab Dis. 1999 Oct;22(7):765-72. [PubMed:10518276 ]
|
|
---|
Associated OMIM IDs | - 123400 (Creutzfeldt-Jakob disease)
- 603903 (Sickle cell anemia)
- 126200 (Multiple sclerosis)
- 601367 (Stroke)
- 236200 (Homocystinuria)
- 168600 (Parkinson's disease)
- 105400 (Amyotrophic lateral sclerosis)
- 272300 (Sulfite oxidase deficiency, ISOLATED)
- 236250 (Methylenetetrahydrofolate reductase deficiency)
- 219500 (Cystathioninuria)
- 252150 (Molybdenium co-factor deficiency)
- 605850 (Dimethylglycine Dehydrogenase Deficiency)
- 167320 (Dementia)
- 104300 (Alzheimer's disease)
- 114500 (Colorectal cancer)
- 275350 (Transcobalamin II deficiency)
|
---|
External Links |
---|
DrugBank ID | DB04422 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB001491 |
---|
KNApSAcK ID | C00001365 |
---|
Chemspider ID | 82666 |
---|
KEGG Compound ID | C00155 |
---|
BioCyc ID | HOMO-CYS |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Homocysteine |
---|
METLIN ID | 3256 |
---|
PubChem Compound | 91552 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 17588 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | HCYS_L |
---|
MarkerDB ID | MDB00013433 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Karrenbauer, Michael; Kleemann, Axel; Luessling, Theodor; Schaefer, Fritz. D,L-Homocysteine (I). Ger. (1984), 4 pp. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Selley ML, Close DR, Stern SE: The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):383-8. [PubMed:11959400 ]
- Yu CK, Lakasing L, Papageorghiou AT, Spencer K, Nicolaides KH: Uterine artery Doppler and mid-trimester maternal plasma homocysteine in subsequent pre-eclampsia. J Matern Fetal Neonatal Med. 2004 Aug;16(2):134-9. [PubMed:15512726 ]
- Giladi N, Mordechovich M, Gruendlinger L, Shabtai H, Merims D, Naor S, Baltadzhieva R, Hausdorff JM, Gur AY, Bornstein NM: "Brain Screen": A self-referral, screening program for strokes, falls and dementia risk factors. J Neurol. 2006 Mar;253(3):307-15. Epub 2005 Oct 10. [PubMed:16208527 ]
- Terzolo M, Allasino B, Bosio S, Brusa E, Daffara F, Ventura M, Aroasio E, Sacchetto G, Reimondo G, Angeli A, Camaschella C: Hyperhomocysteinemia in patients with Cushing's syndrome. J Clin Endocrinol Metab. 2004 Aug;89(8):3745-51. [PubMed:15292300 ]
- Laxdal E, Eide GE, Amundsen SR, Dregelid EB, Pedersen G, Jonung T, Aune S: Homocysteine levels, haemostatic risk factors and restenosis after carotid thrombendarterectomy. Eur J Vasc Endovasc Surg. 2004 Sep;28(3):323-8. [PubMed:15288638 ]
- Akoglu B, Wondra K, Caspary WF, Faust D: Determinants of fasting total serum homocysteine levels in liver transplant recipients. Exp Clin Transplant. 2006 Jun;4(1):462-6. [PubMed:16827644 ]
- Krantz JS, Mack WJ, Hodis HN, Liu CR, Liu CH, Kaufman FR: Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr. 2004 Oct;145(4):452-7. [PubMed:15480366 ]
- Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1585-7. [PubMed:16227558 ]
- Hershcovici T, Schechner V, Orlin J, Harell D, Beigel Y: Effect of different LDL-apheresis methods on parameters involved in atherosclerosis. J Clin Apher. 2004;19(2):90-7. [PubMed:15274202 ]
- Muller T, Renger K, Kuhn W: Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration. Arch Neurol. 2004 May;61(5):657-60. [PubMed:15148140 ]
- Eskes TK: Homocysteine and human reproduction. Clin Exp Obstet Gynecol. 2000;27(3-4):157-67. [PubMed:11214939 ]
- Winkelmayer WC, Kramar R, Curhan GC, Chandraker A, Endler G, Fodinger M, Horl WH, Sunder-Plassmann G: Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol. 2005 Jan;16(1):255-60. Epub 2004 Nov 24. [PubMed:15563562 ]
- Park BH, Kim YJ, Park JS, Lee HY, Ha EH, Min JW, Park HS: [Folate and homocysteine levels during pregnancy affect DNA methylation in human placenta]. J Prev Med Public Health. 2005 Nov;38(4):437-42. [PubMed:16358830 ]
- Hossain GS, van Thienen JV, Werstuck GH, Zhou J, Sood SK, Dickhout JG, de Koning AB, Tang D, Wu D, Falk E, Poddar R, Jacobsen DW, Zhang K, Kaufman RJ, Austin RC: TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia. J Biol Chem. 2003 Aug 8;278(32):30317-27. Epub 2003 May 8. [PubMed:12738777 ]
- Schafer SA, Mussig K, Stefan N, Haring HU, Fritsche A, Balletshofer BM: Plasma homocysteine concentrations in young individuals at increased risk of type 2 diabetes are associated with subtle differences in glomerular filtration rate but not with insulin resistance. Exp Clin Endocrinol Diabetes. 2006 Jun;114(6):306-9. [PubMed:16868889 ]
- Tchantchou F: Homocysteine metabolism and various consequences of folate deficiency. J Alzheimers Dis. 2006 Aug;9(4):421-7. [PubMed:16917151 ]
- Siroka R, Trefil L, Rajdl D, Racek J, Rusnakova H, Cibulka R, Eiselt J, Filipovsky J: Asymmetric dimethylarginine, homocysteine and renal function--is there a relation? Clin Chem Lab Med. 2005;43(10):1147-50. [PubMed:16197312 ]
- Onalan R, Onalan G, Gunenc Z, Karabulut E: Combining 2nd-trimester maternal serum homocysteine levels and uterine artery Doppler for prediction of preeclampsia and isolated intrauterine growth restriction. Gynecol Obstet Invest. 2006;61(3):142-8. Epub 2005 Dec 20. [PubMed:16374017 ]
- Robinson G, Narasimhan S, Weatherall M, Beasley R: Raised plasma homocysteine levels in alcoholism: increasing the risk of heart disease and dementia? N Z Med J. 2005 Jun 3;118(1216):U1490. [PubMed:15937525 ]
- Gulsen M, Yesilova Z, Bagci S, Uygun A, Ozcan A, Ercin CN, Erdil A, Sanisoglu SY, Cakir E, Ates Y, Erbil MK, Karaeren N, Dagalp K: Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2005 Sep;20(9):1448-55. [PubMed:16105135 ]
- Joubert LM, Manore MM: Exercise, nutrition, and homocysteine. Int J Sport Nutr Exerc Metab. 2006 Aug;16(4):341-61. [PubMed:17136938 ]
- Brosnan JT: Homocysteine and cardiovascular disease: interactions between nutrition, genetics and lifestyle. Can J Appl Physiol. 2004 Dec;29(6):773-80. [PubMed:15630149 ]
- Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24. [PubMed:22626821 ]
|
---|